Di questo nessuno ne ha sentito parlare?
OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate - Pipelinereview
OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate
pipelinereview.com
US Patent for Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene Patent (Patent # 11,118,184 issued September 14, 2021) - Justia Patents Search
The present invention relates to an asymmetric siRNA which inhibits an expression of male pattern hair loss target genes and a use thereof and, more particularly, to an asymmetric siRNA which inhibits an expression of 3-oxo-5-alpha-steroid-4-dehydrogenase 1 (SRD5A1) gene...
patents.justia.com